Curcumin and o-Vanillin Exhibit Evidence of Senolytic Activity in Human IVD Cells In Vitro
Curcumin and o-Vanillin cleared senescent intervertebral disc (IVD) cells and reduced the senescence-associated secretory phenotype (SASP) associated with inflammation and back pain. Cells from degenerate and non-mildly-degenerate human IVD were obtained from organ donors and from patients undergoin...
Gespeichert in:
Veröffentlicht in: | Journal of clinical medicine 2019-03, Vol.8 (4), p.433 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 4 |
container_start_page | 433 |
container_title | Journal of clinical medicine |
container_volume | 8 |
creator | Cherif, Hosni Bisson, Daniel G Jarzem, Peter Weber, Michael Ouellet, Jean A Haglund, Lisbet |
description | Curcumin and o-Vanillin cleared senescent intervertebral disc (IVD) cells and reduced the senescence-associated secretory phenotype (SASP) associated with inflammation and back pain. Cells from degenerate and non-mildly-degenerate human IVD were obtained from organ donors and from patients undergoing surgery for low back pain. Gene expression of senescence and SASP markers was evaluated by RT-qPCR in isolated cells, and protein expression of senescence, proliferation, and apoptotic markers was evaluated by immunocytochemistry (ICC). The expression levels of SASP factors were evaluated by enzyme-linked immunosorbent assay (ELISA). Matrix synthesis was verified with safranin-O staining and the Dimethyl-Methylene Blue Assay for proteoglycan content. Western blotting and ICC were used to determine the molecular pathways targeted by the drugs. We found a 40% higher level of senescent cells in degenerate compared to non-mildly-degenerate discs from unrelated individuals and a 10% higher level in degenerate compared to non-mildly-degenerate discs from the same individual. Higher levels of senescence were associated with increased SASP. Both drugs cleared senescent cells, and treatment increased the number of proliferating as well as apoptotic cells in cultures from degenerate IVDs. The expression of SASP factors was decreased, and matrix synthesis increased following treatment. These effects were mediated through the Nrf2 and NFkB pathways. |
doi_str_mv | 10.3390/jcm8040433 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6518239</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2202200800</sourcerecordid><originalsourceid>FETCH-LOGICAL-c374t-a4173abb8f61cb2a03335dd5673ea20d844282e57ac570f6297382dd3ce5dfbb3</originalsourceid><addsrcrecordid>eNpVkU1LxDAQhoMorqgXf4DkKEJ1mmk36UWQddWFBQ_qHryENEndLG2iTbu4_96K30NgJszDO8m8hBylcIZYwPlKNwIyyBC3yB4DzhNAgdt_6hE5jHEFQwiRsZTvkhFCgVkBbI88TfpW943zVHlDQ7JQ3tX1cJ2-LV3pOjpdO2O9tjRU9N76UG86p-ml7tzadRs6kLd9ozydLa7oxNZ1pDNPF65rwwHZqVQd7eFX3ieP19OHyW0yv7uZTS7niUaedYnKUo6qLEU1TnXJFCBibkw-5mgVAyOyjAlmc650zqEas4KjYMagtrmpyhL3ycWn7ktfNtZo67tW1fKldY1qNzIoJ_93vFvK57CW4zwVDItB4ORLoA2vvY2dbFzUw1-Ut6GPkjEYDgiAAT39RHUbYmxt9TMmBfnhh_z1Y4CP_z7sB_3ePr4D8KyF3w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2202200800</pqid></control><display><type>article</type><title>Curcumin and o-Vanillin Exhibit Evidence of Senolytic Activity in Human IVD Cells In Vitro</title><source>PubMed Central Open Access</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Cherif, Hosni ; Bisson, Daniel G ; Jarzem, Peter ; Weber, Michael ; Ouellet, Jean A ; Haglund, Lisbet</creator><creatorcontrib>Cherif, Hosni ; Bisson, Daniel G ; Jarzem, Peter ; Weber, Michael ; Ouellet, Jean A ; Haglund, Lisbet</creatorcontrib><description>Curcumin and o-Vanillin cleared senescent intervertebral disc (IVD) cells and reduced the senescence-associated secretory phenotype (SASP) associated with inflammation and back pain. Cells from degenerate and non-mildly-degenerate human IVD were obtained from organ donors and from patients undergoing surgery for low back pain. Gene expression of senescence and SASP markers was evaluated by RT-qPCR in isolated cells, and protein expression of senescence, proliferation, and apoptotic markers was evaluated by immunocytochemistry (ICC). The expression levels of SASP factors were evaluated by enzyme-linked immunosorbent assay (ELISA). Matrix synthesis was verified with safranin-O staining and the Dimethyl-Methylene Blue Assay for proteoglycan content. Western blotting and ICC were used to determine the molecular pathways targeted by the drugs. We found a 40% higher level of senescent cells in degenerate compared to non-mildly-degenerate discs from unrelated individuals and a 10% higher level in degenerate compared to non-mildly-degenerate discs from the same individual. Higher levels of senescence were associated with increased SASP. Both drugs cleared senescent cells, and treatment increased the number of proliferating as well as apoptotic cells in cultures from degenerate IVDs. The expression of SASP factors was decreased, and matrix synthesis increased following treatment. These effects were mediated through the Nrf2 and NFkB pathways.</description><identifier>ISSN: 2077-0383</identifier><identifier>EISSN: 2077-0383</identifier><identifier>DOI: 10.3390/jcm8040433</identifier><identifier>PMID: 30934902</identifier><language>eng</language><publisher>Switzerland: MDPI</publisher><ispartof>Journal of clinical medicine, 2019-03, Vol.8 (4), p.433</ispartof><rights>2019 by the authors. 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c374t-a4173abb8f61cb2a03335dd5673ea20d844282e57ac570f6297382dd3ce5dfbb3</citedby><cites>FETCH-LOGICAL-c374t-a4173abb8f61cb2a03335dd5673ea20d844282e57ac570f6297382dd3ce5dfbb3</cites><orcidid>0000-0002-1288-2149</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518239/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518239/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30934902$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cherif, Hosni</creatorcontrib><creatorcontrib>Bisson, Daniel G</creatorcontrib><creatorcontrib>Jarzem, Peter</creatorcontrib><creatorcontrib>Weber, Michael</creatorcontrib><creatorcontrib>Ouellet, Jean A</creatorcontrib><creatorcontrib>Haglund, Lisbet</creatorcontrib><title>Curcumin and o-Vanillin Exhibit Evidence of Senolytic Activity in Human IVD Cells In Vitro</title><title>Journal of clinical medicine</title><addtitle>J Clin Med</addtitle><description>Curcumin and o-Vanillin cleared senescent intervertebral disc (IVD) cells and reduced the senescence-associated secretory phenotype (SASP) associated with inflammation and back pain. Cells from degenerate and non-mildly-degenerate human IVD were obtained from organ donors and from patients undergoing surgery for low back pain. Gene expression of senescence and SASP markers was evaluated by RT-qPCR in isolated cells, and protein expression of senescence, proliferation, and apoptotic markers was evaluated by immunocytochemistry (ICC). The expression levels of SASP factors were evaluated by enzyme-linked immunosorbent assay (ELISA). Matrix synthesis was verified with safranin-O staining and the Dimethyl-Methylene Blue Assay for proteoglycan content. Western blotting and ICC were used to determine the molecular pathways targeted by the drugs. We found a 40% higher level of senescent cells in degenerate compared to non-mildly-degenerate discs from unrelated individuals and a 10% higher level in degenerate compared to non-mildly-degenerate discs from the same individual. Higher levels of senescence were associated with increased SASP. Both drugs cleared senescent cells, and treatment increased the number of proliferating as well as apoptotic cells in cultures from degenerate IVDs. The expression of SASP factors was decreased, and matrix synthesis increased following treatment. These effects were mediated through the Nrf2 and NFkB pathways.</description><issn>2077-0383</issn><issn>2077-0383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNpVkU1LxDAQhoMorqgXf4DkKEJ1mmk36UWQddWFBQ_qHryENEndLG2iTbu4_96K30NgJszDO8m8hBylcIZYwPlKNwIyyBC3yB4DzhNAgdt_6hE5jHEFQwiRsZTvkhFCgVkBbI88TfpW943zVHlDQ7JQ3tX1cJ2-LV3pOjpdO2O9tjRU9N76UG86p-ml7tzadRs6kLd9ozydLa7oxNZ1pDNPF65rwwHZqVQd7eFX3ieP19OHyW0yv7uZTS7niUaedYnKUo6qLEU1TnXJFCBibkw-5mgVAyOyjAlmc650zqEas4KjYMagtrmpyhL3ycWn7ktfNtZo67tW1fKldY1qNzIoJ_93vFvK57CW4zwVDItB4ORLoA2vvY2dbFzUw1-Ut6GPkjEYDgiAAT39RHUbYmxt9TMmBfnhh_z1Y4CP_z7sB_3ePr4D8KyF3w</recordid><startdate>20190329</startdate><enddate>20190329</enddate><creator>Cherif, Hosni</creator><creator>Bisson, Daniel G</creator><creator>Jarzem, Peter</creator><creator>Weber, Michael</creator><creator>Ouellet, Jean A</creator><creator>Haglund, Lisbet</creator><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1288-2149</orcidid></search><sort><creationdate>20190329</creationdate><title>Curcumin and o-Vanillin Exhibit Evidence of Senolytic Activity in Human IVD Cells In Vitro</title><author>Cherif, Hosni ; Bisson, Daniel G ; Jarzem, Peter ; Weber, Michael ; Ouellet, Jean A ; Haglund, Lisbet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c374t-a4173abb8f61cb2a03335dd5673ea20d844282e57ac570f6297382dd3ce5dfbb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cherif, Hosni</creatorcontrib><creatorcontrib>Bisson, Daniel G</creatorcontrib><creatorcontrib>Jarzem, Peter</creatorcontrib><creatorcontrib>Weber, Michael</creatorcontrib><creatorcontrib>Ouellet, Jean A</creatorcontrib><creatorcontrib>Haglund, Lisbet</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cherif, Hosni</au><au>Bisson, Daniel G</au><au>Jarzem, Peter</au><au>Weber, Michael</au><au>Ouellet, Jean A</au><au>Haglund, Lisbet</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Curcumin and o-Vanillin Exhibit Evidence of Senolytic Activity in Human IVD Cells In Vitro</atitle><jtitle>Journal of clinical medicine</jtitle><addtitle>J Clin Med</addtitle><date>2019-03-29</date><risdate>2019</risdate><volume>8</volume><issue>4</issue><spage>433</spage><pages>433-</pages><issn>2077-0383</issn><eissn>2077-0383</eissn><abstract>Curcumin and o-Vanillin cleared senescent intervertebral disc (IVD) cells and reduced the senescence-associated secretory phenotype (SASP) associated with inflammation and back pain. Cells from degenerate and non-mildly-degenerate human IVD were obtained from organ donors and from patients undergoing surgery for low back pain. Gene expression of senescence and SASP markers was evaluated by RT-qPCR in isolated cells, and protein expression of senescence, proliferation, and apoptotic markers was evaluated by immunocytochemistry (ICC). The expression levels of SASP factors were evaluated by enzyme-linked immunosorbent assay (ELISA). Matrix synthesis was verified with safranin-O staining and the Dimethyl-Methylene Blue Assay for proteoglycan content. Western blotting and ICC were used to determine the molecular pathways targeted by the drugs. We found a 40% higher level of senescent cells in degenerate compared to non-mildly-degenerate discs from unrelated individuals and a 10% higher level in degenerate compared to non-mildly-degenerate discs from the same individual. Higher levels of senescence were associated with increased SASP. Both drugs cleared senescent cells, and treatment increased the number of proliferating as well as apoptotic cells in cultures from degenerate IVDs. The expression of SASP factors was decreased, and matrix synthesis increased following treatment. These effects were mediated through the Nrf2 and NFkB pathways.</abstract><cop>Switzerland</cop><pub>MDPI</pub><pmid>30934902</pmid><doi>10.3390/jcm8040433</doi><orcidid>https://orcid.org/0000-0002-1288-2149</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2077-0383 |
ispartof | Journal of clinical medicine, 2019-03, Vol.8 (4), p.433 |
issn | 2077-0383 2077-0383 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6518239 |
source | PubMed Central Open Access; MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central |
title | Curcumin and o-Vanillin Exhibit Evidence of Senolytic Activity in Human IVD Cells In Vitro |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T04%3A56%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Curcumin%20and%20o-Vanillin%20Exhibit%20Evidence%20of%20Senolytic%20Activity%20in%20Human%20IVD%20Cells%20In%20Vitro&rft.jtitle=Journal%20of%20clinical%20medicine&rft.au=Cherif,%20Hosni&rft.date=2019-03-29&rft.volume=8&rft.issue=4&rft.spage=433&rft.pages=433-&rft.issn=2077-0383&rft.eissn=2077-0383&rft_id=info:doi/10.3390/jcm8040433&rft_dat=%3Cproquest_pubme%3E2202200800%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2202200800&rft_id=info:pmid/30934902&rfr_iscdi=true |